-
Novartis Dissolves CAR-T Unit Cutting 120 Positions
Forbes | Novartis is shutting down the business unit it created to develop white blood cells that can attack certain types of cancer, but continuing to develop such projects known as chimeric antigen receptor T-cells, or CAR-Ts.
Aug 31, 2016
-
Say hello to Dell Technologies on Sept. 7
Computerworld | Dell will complete its acquisition of EMC on Sept. 7, ending nearly a year of approvals and decades of history for the two companies that will combine to become Dell Technologies.
Aug 30, 2016
-
Excel Auto-Correct Creates Problems With Genomics Research
PCMAG | An Excel auto-correct feature changes gene names to dates. An Australian group dug through 7,500 Excel files published in 18 journals. About 20% of the files had errors.
Aug 30, 2016
-
tranSMART, IDBS, JAX and more: News from August 2016
Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from tranSMART, JAX, Internet2, IDBS, Synthego, and more.
Aug 30, 2016
-
The Genetics of Type 2 Diabetes Is a Mess
Pacific Standard | A recent study shows why genetic advances in medicine are so challenging.
Aug 29, 2016
-
Digitizing The Pharma Research Value Chain For Faster Drug Discovery Through Precompetitive Collaboration
Bio-IT World Contributed Commentary | The global pharmaceutical industry is at a crossroads. It is, therefore, imperative for pharma organizations to reimagine their research value chain, in order to accelerate product innovation, and boost molecule pipelines during the discovery stage.
Aug 26, 2016
-
Stealthy Biotech Revives Stalled Parkinsons Drug Reveals Plans In Alzheimers and ALS
Forbes | Denali Therapeutics, the stealthy South San Francisco biotech startup that raised $217 million last year to fight Alzheimer's, Parkinson's and ALS, is finally lifting the curtain on its plans this morning.
Aug 25, 2016
-
Obama’s science legacy betting big on biomedical science
Nature News & Comment | Ambitious bids to map the brain and cure cancer have not boosted overall research funding.
Aug 22, 2016
-
With $14 Billion Purchase Pfizer Signals That Cancer Drug Prices Will Remain High
Forbes | Pfizer says it will purchase biotechnology upstart Medivation for $14 billion in cash. The main prize in the deal: Medivation's prostate cancer drug, Xtandi, which costs $120,000 a year.
Aug 22, 2016
-
Mass Innovation Labs Host Space for Growing Biotech
Bio-IT World “Something that the industry doesn’t really talk about is the cost of doing research,” says Amrit Chaudhuri, CEO of Mass Innovation Labs in Cambridge, Mass. Running a lab can cost hundreds of dollars per square foot, Chaudhuri says, but Mass Innovation Labs offers an alternative.
Aug 18, 2016
-
Lies damn lies and CRISPR the legal battle escalates
STAT | The gloves are off in the legal fight over CRISPR genome editing patents, as the latest documents filed in the case make clear.
Aug 18, 2016
-
ExAC Project Pins Down Rare Gene Variants
Nature News & Comment | Catalogue of genetic information from some 60,000 people reveals unexpected surprises - and highlights the need to make genomic data publicly accessible to aid studies of rare diseases.
Aug 17, 2016
-
ARM pact Will Help Intel Woo Apple Into New Chip Deal
Computerworld | The chances of Apple's using Intel's factories to have its iPhone and iPad chips made have just rocketed up.
Aug 17, 2016
-
Spiking genomic databases with misinformation could protect patient privacy
Nature News & Comment | Technique that adds noise to genetic data would enable much faster access to large data sets.
Aug 16, 2016
-
Why CRISPR Is An Attractive Approach To Treat Sickle Cell Disease
Forbes | Researchers describe a new way to use CRISPR editing to fix sickle cell disease, a debilitating genetic blood disorder.
Aug 16, 2016
-
Ayar Labs Gets $2.5M to Go After Optical Chips for Data Centers
Xconomy | This startup sits at the intersection of electronics, optics, energy efficiency, and the Internet. Ayar Labs is working on how to make data centers perform better with less energy.
Aug 16, 2016
-
Beyond CRISPR: A Guide to the Many Other Ways to Edit a Genome
Nature News | The surge of activity in recent years around CRISPR-Cas9 gene editing has also led to a flurry of modified CRISPR systems, or new systems entirely, which are starting to solve problems like delivering enzymes into cells, making specific changes to the DNA sequence, and editing RNA as well as DNA.
Aug 11, 2016
-
Intel Buys Deep-Learning Startup Nervana to Bolster Machine Learning Chops
Computerworld | Intel is buying Nervana Systems, a deep learning startup based out of California. The deal speaks volumes about Intel's hopes for the future and where the company is going.
Aug 10, 2016
-
Broad's GATK Dominates as Genomics Go-To
Bio-IT World | As the Genome Analysis Toolkit, developed at the Broad Institute, continues to serve as the standby for parsing raw genomic data in public projects and major institutions, members of the Broad speak to Bio-IT World about forthcoming updates in GATK4 and new ventures incorporating the toolkit.
Aug 10, 2016
-
Google, Stanford Medicine Team Up on Genomics
Fast Company | The school will adopt the Google Genomics cloud platform to improve how it treats patients with cancer, as well as to diagnose children with mysterious, rare diseases.
Aug 9, 2016